Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SVA

+ Watchlist+ Portfolio

Sinovac Biotech, Ltd.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$6.47
52-Week Range
$6.47 – $6.47
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Dividend Yield
—
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
—
Gross Margin
—
Operating Margin
—
Profit Margin
—
Current Ratio
—
Debt/Equity
—
Total Debt
—
Free Cash Flow
—
Revenue Growth
—
Earnings Growth
—
Enterprise Value
—

Market Snapshot

About

Sinovac Biotech, Ltd. is a China-based biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines. The company is known for developing vaccines against infectious diseases including hepatitis, influenza, and COVID-19. Sinovac gained international recognition during the COVID-19 pandemic with its CoronaVac vaccine.